Pelthos Therapeutics Stock Price, News & Analysis
PTHS
NYSE
Company Description
Welcome to the overview page for Pelthos Therapeutics (PTHS), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$3,448,939
Net Income (TTM)
$5.38
$1,079,271
Operating Cash Flow
0.11
$3,230,423
—
Revenue (TTM)
Upcoming Events
Frequently Asked Questions
What is the current stock price of Pelthos Therapeutics (PTHS)?
The current stock price of Pelthos Therapeutics (PTHS) is $23.6505 as of September 1, 2025.
What is the market cap of Pelthos Therapeutics (PTHS)?
The market cap of Pelthos Therapeutics (PTHS) is approximately 71.9M. Learn more about what market capitalization means.
What is the net income of Pelthos Therapeutics (PTHS)?
The trailing twelve months (TTM) net income of Pelthos Therapeutics (PTHS) is $3,448,939.
What is the earnings per share (EPS) of Pelthos Therapeutics (PTHS)?
The diluted earnings per share (EPS) of Pelthos Therapeutics (PTHS) is $5.38 on a trailing twelve months (TTM) basis. Learn more about EPS.
What is the operating cash flow of Pelthos Therapeutics (PTHS)?
The operating cash flow of Pelthos Therapeutics (PTHS) is $1,079,271. Learn about cash flow.
What is the current ratio of Pelthos Therapeutics (PTHS)?
The current ratio of Pelthos Therapeutics (PTHS) is 0.11, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Pelthos Therapeutics (PTHS)?
The operating income of Pelthos Therapeutics (PTHS) is $3,230,423. Learn about operating income.